Compass Opioid Stewardship 2026 Virtual Symposium-FREE NO CME-06-Medical Legal Case Presentation-Don Stader-Handouts

06-Medical Legal Case Presentation-Don Stader-Handouts

Pdf Summary

The document is a slide excerpt from the Compass Opioid Stewardship 2026 Virtual Symposium session for medical board investigators, presented by Don Stader, MD (March 7, 2026). It emphasizes how controlled-substance (CS) opioid prescribing is evaluated by oversight bodies and how clinicians can avoid or respond to medical-legal problems. The session uses a case study loosely based on a real Compass submission (details altered to protect identities) and clarifies that case discussion does not establish a provider–patient relationship.<br /><br />Key learning objectives are to evaluate a real-world medical board investigation, understand the standards applied to prescribing practices, and translate lessons into safer opioid prescribing and risk-mitigation strategies. The slides list common reasons for medical board complaints related to opioid/CS prescribing: overprescribing or high doses, lack of medical necessity, inadequate patient evaluation, poor documentation, dangerous drug combinations, failure to monitor, ignoring red flags for misuse/diversion, prescribing outside one’s scope/competency, and regulatory violations.<br /><br />Guidance for clinicians who receive a complaint includes: pause and stay calm, contact an attorney experienced with board complaints, and avoid signing documents without legal consultation and consideration of long-term consequences. The “snowball effect” is highlighted—medical board actions can trigger additional consequences such as DEA investigations, medical staff privilege restrictions through peer review, and malpractice insurance premium increases (often 50–200%); the example case resulted in a 50% increase after appeals.<br /><br />DEA investigation takeaways include treating every interaction as a legal proceeding, working through an attorney, and maintaining strong compliance and records. The slides also note broad costs of investigations: legal fees, insurance impacts, mandated monitoring expenses, and significant mental health and professional effects (anxiety, depression, burnout, altered clinical decision-making). Overall takeaways stress prevention through consistent opioid stewardship, thorough documentation, routine risk mitigation, and early response to red flags.

Keywords

Opioid stewardship

Controlled substance prescribing

Medical board investigation

Opioid prescribing compliance

Documentation standards

Risk mitigation strategies

DEA investigation

Overprescribing high-dose opioids

Red flags misuse diversion

Medical-legal defense attorney